英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Tofisopam Impurity 6 |
托非索泮雜質(zhì)6 |
15462-91-6 |
詳細(xì)
|
Tolterodine EP Impurity C HCl |
托特羅定EP雜質(zhì)C |
1161940-88-0 |
詳細(xì)
|
Tolterodine EP Impurity G |
托特羅定EP雜質(zhì)G |
1554029-91-2 |
詳細(xì)
|
Tolfenamic Acid Impurity |
托芬那酸雜質(zhì) |
1609192-68-8 |
詳細(xì)
|
Toladryl (Diphenhydramine EP Impurity B, Dimenhydrinate EP Impurity G, Orphenadrine EP Impurity F, Orphenadrine USP Related Compound F (Free Form)) |
新苯海拉明(托拉代爾,苯海拉明EP雜質(zhì)B) |
19804-27-4 |
詳細(xì)
|
Tolnaftate Impurity 4 (2-Naphthyl Ether) |
托萘酯雜質(zhì)4 |
613-80-9 |
詳細(xì)
|
Tolnaftate Impurity 6 (Sudan I) |
托萘酯雜質(zhì)6 |
842-07-9 |
詳細(xì)
|
Tolnaftate EP Impurity D |
托萘酯EP雜質(zhì)D |
696-44-6 |
詳細(xì)
|
Toladryl HCl (Diphenhydramine EP Impurity B HCl, Dimenhydrinate EP Impurity G HCl, Orphenadrine EP Impurity F HCl, Orphenadrine USP Related Compound F HCl) |
新苯海拉明鹽酸鹽(鹽酸托拉代爾) |
4024-34-4 |
詳細(xì)
|
Tolnaftate Impurity 5 Disodium Salt |
托萘酯雜質(zhì)5 |
61551-82-4 |
詳細(xì)
|
Tolnaftate Impurity 7 |
托萘酯雜質(zhì)7 |
128726-56-7 |
詳細(xì)
|
Tofisopam Impurity 7 |
托非索泮雜質(zhì)7 |
37952-09-3 |
詳細(xì)
|
Topiramate Impurity 11 |
托吡酯雜質(zhì)11 |
120238-48-4 |
詳細(xì)
|
Topiramate Impurity 12 |
托吡酯雜質(zhì)12 |
53209-16-8 |
詳細(xì)
|
Tolvaptan Impurity 1 (DM-4103) |
托伐普坦雜質(zhì)1 |
1346599-56-1 |
詳細(xì)
|
Torasemide (Torsemide) Impurity 16 |
托拉塞米雜質(zhì)16 |
2594-20-9 |
詳細(xì)
|
Torasemide (Torsemide) Impurity 17 |
托拉塞米雜質(zhì)17 |
2132406-44-9 |
詳細(xì)
|
2,3:4,5‐Bis‐O‐(1‐methylethylidene)‐‐D‐fructopyranose |
托吡酯雜質(zhì)D |
25018-67-1 |
詳細(xì)
|
Topiramate Impurity 13 |
托吡酯雜質(zhì)13 |
53209-14-6 |
詳細(xì)
|
Topiramate N-Methyl Impurity |
N-甲基托吡酯雜質(zhì) |
97240-80-7 |
詳細(xì)
|
Topiramate Didesacetal Impurity |
托吡酯脫二乙縮醛雜質(zhì) |
106881-42-9 |
詳細(xì)
|
Topiramate EP Impurity C (4,5-Diol Topiramate) |
托吡酯EP雜質(zhì)C |
106881-41-8 |
詳細(xì)
|
Toremifene Impurity 4 |
托瑞米芬雜質(zhì)4 |
97151-04-7 |
詳細(xì)
|
Toremifene Impurity 5 |
托瑞米芬雜質(zhì)5 |
89778-20-1 |
詳細(xì)
|
Toremifene Impurity 1 |
托瑞米芬雜質(zhì)1 |
97151-03-6 |
詳細(xì)
|
Tosufloxacin Impurity 1 |
托氟沙星(妥舒沙星)雜質(zhì)1 |
96568-04-6 |
詳細(xì)
|
Trabectedin Impurity 3 |
曲貝替定雜質(zhì)3 |
114899-80-8 |
詳細(xì)
|
Trabectedin Impurity 4 |
曲貝替定雜質(zhì)4 |
631920-73-5 |
詳細(xì)
|
p-Toluenesulfonic Acid Impurity 2 (Methyl p-Toluenesulfonate) |
對(duì)甲苯磺酸雜質(zhì)2 |
80-48-8 |
詳細(xì)
|
p-Toluenesulfonic Acid Impurity 1 (Phenyl p-Tolyl Sulfone) |
對(duì)甲苯磺酸雜質(zhì)1 |
640-57-3 |
詳細(xì)
|
Tosufloxacin Impurity 2 |
托氟沙星(妥舒沙星)雜質(zhì)2 |
100491-29-0 |
詳細(xì)
|
p-Toluenesulfonic Acid Impurity 3 (3-Methylbutyl Tosylate) |
對(duì)甲苯磺酸雜質(zhì)3 |
2431-75-6 |
詳細(xì)
|
Tramadol Impurity 2 |
曲馬多雜質(zhì)2 |
187219-95-0 |
詳細(xì)
|
MANNICH HCL |
2-(二甲基氨基甲基)-1-鹽酸環(huán)己酮 |
42036-65-7 |
詳細(xì)
|
Tramadol Impurity 3 |
曲馬多雜質(zhì)3 |
273398-39-3 |
詳細(xì)
|
Tralopyril Impurity 1 |
曲洛比利雜質(zhì)1 |
1413929-67-5 |
詳細(xì)
|
Tralopyril Impurity 2 |
曲洛比利雜質(zhì)2 |
890044-32-3 |
詳細(xì)
|
Trabectedin Impurity 5 |
曲貝替定雜質(zhì)5 |
1376626-08-2 |
詳細(xì)
|
Trabectedin Impurity 8 |
曲貝替定雜質(zhì)8 |
182201-61-2 |
詳細(xì)
|
Trabectedin Impurity 7 (QT10) |
曲貝替定雜質(zhì)7 |
577747-80-9 |
詳細(xì)
|
Trandolapril EP Impurity D |
群多普利EP雜質(zhì)D |
149881-40-3 |
詳細(xì)
|
Trametinib Impurity 6 |
曲美替尼雜質(zhì)6 |
871701-87-0 |
詳細(xì)
|
Trametinib Impurity 5 |
曲美替尼雜質(zhì)5 |
871700-24-2 |
詳細(xì)
|
Trametinib Impurity 7 |
曲美替尼雜質(zhì)7 |
871700-25-3 |
詳細(xì)
|
Trametinib Impurity 3 |
曲美替尼雜質(zhì)3 |
871700-65-1 |
詳細(xì)
|
Trandolapril Impurity 10 |
群多普利雜質(zhì)10 |
1404480-04-1 |
詳細(xì)
|
Trandolapril EP Impurity E (Trandolapril USP Related Compound E, Trandolaprilat) |
群多普利EP雜質(zhì)E |
87679-71-8 |
詳細(xì)
|
Trastuzumab Impurity 3 |
曲妥珠單抗雜質(zhì)3 |
34321-81-8 |
詳細(xì)
|
Trastuzumab Impurity 2 (Fmoc-Val-Cit-PAB-OH) |
曲妥珠單抗雜質(zhì)2 |
159858-22-7 |
詳細(xì)
|
Trazodone EP Impurity I |
曲唑酮EP雜質(zhì)I |
32229-98-4 |
詳細(xì)
|
Trazodone EP (BP) Impurity H DiHCl |
曲唑酮EP雜質(zhì)H |
2408971-27-5 |
詳細(xì)
|
Trazodone Impurity 13-13C3 |
曲唑酮雜質(zhì)13-13C3 |
1173023-11-4 |
詳細(xì)
|
Trandolapril Impurity 13 HCl |
群多普利雜質(zhì)13 |
145682-34-4 |
詳細(xì)
|
Trandolapril EP Impurity A |
群多普利EP雜質(zhì)A |
118194-41-5 |
詳細(xì)
|
Trandolapril Impurity 12 |
群多普利雜質(zhì)12 |
760916-37-8 |
詳細(xì)
|
Tranexamic Acid EP Impurity E |
氨甲環(huán)酸EP雜質(zhì)E |
82755-59-7 |
詳細(xì)
|
Trandolapril Impurity 11 |
群多普利雜質(zhì)11 |
149756-14-9 |
詳細(xì)
|
Tranexamic Acid Impurity 11 (Mixture of Diastereomers) |
氨甲環(huán)酸雜質(zhì)11 |
17770-36-4 |
詳細(xì)
|
Tranylcypromine Impurity 2 |
反苯環(huán)丙胺雜質(zhì)2 |
17364-52-2 |
詳細(xì)
|
Tranylcypromine Impurity 1 |
反苯環(huán)丙胺雜質(zhì)1 |
14561-40-1 |
詳細(xì)
|
Tranexamic Acid EP Impurity D |
氨甲環(huán)酸EP雜質(zhì)D |
56-91-7 |
詳細(xì)
|
Trastuzumab Impurity 1 (Fmoc-Val-Osu) |
曲妥珠單抗雜質(zhì)1 |
130878-68-1 |
詳細(xì)
|
Tranexamic Acid EP Impurity F |
氨甲環(huán)酸EP雜質(zhì)F |
1599413-49-6 |
詳細(xì)
|
Tranexamic Acid EP Impurity C HCl |
氨甲環(huán)酸EP雜質(zhì)C |
1803601-44-6 |
詳細(xì)
|
Tranexamic Acid Impurity 12 |
氨甲環(huán)酸雜質(zhì)12 |
4331-54-8 |
詳細(xì)
|
Treprostinil Impurity 3 |
曲前列尼爾雜質(zhì)3 |
101692-02-8 |
詳細(xì)
|
Triamterene Impurity A |
氨苯蝶啶雜質(zhì)A |
1006-23-1 |
詳細(xì)
|
Triamterene Impurity B |
氨苯蝶啶雜質(zhì)B |
19375-89-4 |
詳細(xì)
|
Triamterene EP Impurity C |
氨苯蝶啶EP雜質(zhì)C |
19152-93-3 |
詳細(xì)
|
Triamcinolone Impurity 6 |
曲安奈德雜質(zhì)6 |
159210-07-8 |
詳細(xì)
|
Triamcinolone Acetonide EP Impurity F (Triamcinolone Acetonide 21-Acetate) |
醋酸曲安奈德EP雜質(zhì)F |
3870-07-3 |
詳細(xì)
|
Triamcinolone Impurity 4 |
曲安奈德雜質(zhì)4 |
3800-28-0 |
詳細(xì)
|
Triamcinolone Impurity 5 |
曲安奈德雜質(zhì)5 |
53962-41-7 |
詳細(xì)
|
Tretinoin Impurity 3 |
維A酸雜質(zhì)3 |
873778-64-4 |
詳細(xì)
|
Isotretinoin Impurity 3 |
異維A酸雜質(zhì)3 |
39760-56-0 |
詳細(xì)
|
Isotretinoin Impurity 2 |
異維A酸雜質(zhì)2 |
51318-62-8 |
詳細(xì)
|
Tretinoin Impurity 2 |
維A酸雜質(zhì)2 |
193416-09-0 |
詳細(xì)
|
Isotretinoin EP Impurity H (4-Oxo-13-cis-Retinoic Acid) |
異維A酸EP雜質(zhì)H |
71748-58-8 |
詳細(xì)
|
Tretinoin Impurity 1 |
維A酸雜質(zhì)1 |
129454-96-2 |
詳細(xì)
|
Treprostinil Impurity 6 |
曲前列尼爾雜質(zhì)6 |
101692-03-9 |
詳細(xì)
|
Treprostinil Impurity 9 |
曲前列尼爾雜質(zhì)9 |
1345337-82-7 |
詳細(xì)
|
Treprostinil Impurity 11 |
曲前列尼爾雜質(zhì)11 |
1911575-29-5 |
詳細(xì)
|
Tretinoin EP Impurity F (4-Methoxy Retinoic Acid) |
維A酸EP雜質(zhì)F |
81121-20-2 |
詳細(xì)
|
Isotretinoin EP Impurity F |
異維A酸EP雜質(zhì)F |
68070-35-9 |
詳細(xì)
|
Isotretinoin EP Impurity I (13-cis-4-Hydroxy-Retinoic Acid, 4-Hydroxy Isotretinoin) |
異維A酸EP雜質(zhì)I |
75281-25-3 |
詳細(xì)
|
Triamcinolone Acetonide Impurity E (9-Chloro Triamcinolone Acetonide 21-Acetate) |
醋酸曲安奈德雜質(zhì)E |
10392-75-3 |
詳細(xì)
|
Triamcinolone Acetonide EP Impurity E |
醋酸曲安奈德EP雜質(zhì)E |
1524-86-3 |
詳細(xì)
|
Triamcinolone Acetonide Impurity 1 |
醋酸曲安奈德雜質(zhì)1 |
2367-73-9 |
詳細(xì)
|
Triamcinolone Acetonide EP Impurity D |
醋酸曲安奈德EP雜質(zhì)D |
10392-74-2 |
詳細(xì)
|
Triamcinolone EP Impurity C (Pretriamcinolone) |
曲安奈德EP雜質(zhì)C |
337-02-0 |
詳細(xì)
|
Tribenuron Impurity 1 |
苯磺隆雜質(zhì)1 |
5248-39-5 |
詳細(xì)
|
Tribenoside Impurity 1 |
三芐糖苷雜質(zhì)1 |
35958-64-6 |
詳細(xì)
|
Tribenoside EP Impurity B |
三芐糖苷EP雜質(zhì)B |
28713-39-5 |
詳細(xì)
|
Tribenoside EP Impurity A |
三芐糖苷EP雜質(zhì)A |
53928-30-6 |
詳細(xì)
|
Trazodone EP (BP) Impurity C HCl |
曲唑酮EP雜質(zhì)C |
1263278-77-8 |
詳細(xì)
|
Trelagliptin Impurity 16 |
曲格列汀雜質(zhì)16 |
1917324-13-0 |
詳細(xì)
|
Trelagliptin Impurity 14 |
曲格列汀雜質(zhì)14 |
2565-47-1 |
詳細(xì)
|
N-Nitroso Trazodone EP Impurity L |
N-亞硝基曲唑酮EP雜質(zhì)L |
2219339-13-4 |
詳細(xì)
|
Trelagliptin Impurity 10 |
曲格列汀雜質(zhì)10 |
2204313-59-5 |
詳細(xì)
|
Tribenuron Impurity 2 |
苯磺隆雜質(zhì)2 |
57683-71-3 |
詳細(xì)
|